Sort by
Keyphrases
Apoptosis
20%
Autoimmunity
20%
Carnitine Palmitoyltransferase 1A (CPT1A)
40%
Central Nervous System Demyelinating Diseases
20%
Cytokine Production
20%
Demyelinating Diseases
20%
Demyelination
20%
Disease Activity
100%
Disease Course
20%
Disease Severity
20%
Effective Treatment
20%
Encephalitogenic T Cells
20%
Experimental Autoimmune Encephalomyelitis
20%
Fatty Acid Metabolism
100%
Fatty Acid β-oxidation
20%
Immune Cells
20%
Immunopathology
20%
Inflammation
40%
Inflammatory Cytokines
20%
Metabolic Pathway
20%
Metabolism
20%
Mouse Model
20%
Multiple Sclerosis
100%
Neurological Impairment
20%
Putative Drug Targets
20%
Rate-limiting Enzyme
20%
Biochemistry, Genetics and Molecular Biology
Animal Model
100%
Autoimmunity
66%
Beta Oxidation
33%
Carnitine Palmitoyltransferase I
66%
Cytokine Production
33%
Downregulation
33%
Enzyme
33%
Fatty Acid Metabolism
100%
Immunocompetent Cell
33%
Inflammatory Cytokine
33%
Metabolic Pathway
66%
Mouse Model
33%
Programmed Cell Death
33%
T Cell
33%
Immunology and Microbiology
Autoimmunity
20%
Central Nervous System
20%
Clinically Isolated Syndrome
20%
Cytokine Production
20%
Downregulation
20%
Experimental Autoimmune Encephalomyelitis
20%
Fatty Acid
20%
Fatty Acid Metabolism
100%
Fatty Acid Oxidation
20%
Immunocompetent Cell
20%
Immunopathology
20%
Inflammatory Cytokine
20%
Mouse Model
20%
Multiple Sclerosis
100%
Programmed Cell Death
20%
T Cell
20%
Neuroscience
Carnitine Palmitoyltransferase I
40%
Central Nervous System
20%
Cytokine Production
20%
Demyelinating Disease
20%
Experimental Autoimmune Encephalomyelitis
20%
Fatty Acids
100%
Metabolic Pathway
100%
Multiple Sclerosis
100%
Programmed Cell Death
20%
T Cell
20%